Woodmont Investment Counsel LLC Purchases Shares of 18,551 Addus HomeCare Corporation (NASDAQ:ADUS)

Woodmont Investment Counsel LLC acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 18,551 shares of the company's stock, valued at approximately $1,835,000. Woodmont Investment Counsel LLC owned 0.10% of Addus HomeCare at the end of the most recent quarter.

A number of other large investors have also modified their holdings of ADUS. Alliancebernstein L.P. grew its stake in shares of Addus HomeCare by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after purchasing an additional 91 shares in the last quarter. Natixis increased its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the last quarter. Heritage Family Offices LLP increased its holdings in shares of Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after acquiring an additional 143 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares in the last quarter. Finally, Stifel Financial Corp boosted its holdings in Addus HomeCare by 1.2% in the fourth quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock valued at $1,604,000 after purchasing an additional 153 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Stock Down 1.2%

ADUS opened at $113.79 on Friday. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72. The business has a 50 day moving average price of $108.91 and a two-hundred day moving average price of $111.98. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. The company has a market cap of $2.09 billion, a PE ratio of 25.69, a P/E/G ratio of 1.63 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the prior year, the business earned $1.21 earnings per share. The company's quarterly revenue was up 20.3% compared to the same quarter last year. As a group, research analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ADUS. Stephens restated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Macquarie reissued an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Friday. Finally, Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Saturday. One analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.